Wellness Market News: Nuritas-Pharmavite Peptides, Abbott Nutriton, Brain Armor, Trade Group Notes

Pharmavite tests bioactive peptides with Nuritas' AI platform; NPA questions FDA proposal to share data collected from US firms; NFL great Randy White promotes Brain Armor supplements; Abbott Nutrition sales up 4.4% for 2018; ONHA targets expanding omega-3 testing among consumers; CRN's Mister, Sidley's Bass co-chair regulatory conference; and 'Hero for the Planet' Plotkin speaks at AHPA meeting.

Organic & Natural Health Association is looking for corporate sponsorship of its campaign to promote consumers' testing for their omega-3 levels after enrolling more than 1,200 people in its study in 2017-2018. The Washington-based organization announced at its national conference in Fort Myers, Fla., Jan. 22-23, that around 5,000 participants are needed to generate sufficient data on health outcomes linked to omega-3 index level values, which participants test every three to six months. ONHA CEO Karen Howard the $100 price for the single-use self-test kits can be a barrier for some people interested in participating in the study the organization and GrassrootsHealth are conducting with a five-year goal of linking increased omega-3 levels to specific health outcomes. "In order to expand this study additional funding to cover the costs of the test kits will help us get there more quickly,” Howard said. Linking use of the fatty acid to specific health outcomes "will give consumers a specific roadmap to boost their omega-3 levels so the current data on omega-3 does not remain arbitrary,” she added.

Artificial intelligence firm Nuritas Ltd. will work with vitamins, minerals and supplements manufacturer [Pharmavite LLC] on discovering bioactive peptide networks to address health and wellness concerns and meet a target...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

People On The Move: Appointments At ANEPF, Inula, Opella

 
• By 

A round-up of the latest consumer health people moves: ANEFP elects president; Inula Group appoints CEO; Opella names ANZ head.

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By 

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.

Time’s Up For Time-Line Mitopure Supplement Marketer’s Aging Claims In NAD Review

 

NAD says Amazentis didn’t substantiate cellular performance and muscle function claims for its supplements containing proprietary ingredient Mitropure but provided “a sufficiently reliable and reasonable basis” for “clinically proven to revitalize mitochondria.”

Haleon Utilizing AI To Develop Natural CHC Products

 
• By 

Haleon is partnering with San Francisco's Brightseed to utilize its AI technology to identify bioactive compounds in plants for use in consumer health products.

More from Wellness

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By 

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.

Time’s Up For Time-Line Mitopure Supplement Marketer’s Aging Claims In NAD Review

 

NAD says Amazentis didn’t substantiate cellular performance and muscle function claims for its supplements containing proprietary ingredient Mitropure but provided “a sufficiently reliable and reasonable basis” for “clinically proven to revitalize mitochondria.”

Kennedy’s Balancing Act: Push MAHA, Trim Regs

 

Same-day announcements of RFIs from HHS secretary cover nutrient review process for infant formula and Kennedy’s “10-to-1 deregulatory policy” as part of president’s “broader federal effort to reduce regulatory burdens and increase transparency.”